Oxydrol 50 mg is an oral oxymetholone tablet manufactured by British Dragon and dosed at 50 mg per tablet, supplied in packs of 50 tablets.
Oxydrol 50 mg contains oxymetholone, a potent 17α-alkylated oral anabolic-androgenic steroid. Oxymetholone is FDA-approved for the treatment of anemias caused by deficient red blood cell production, including acquired aplastic anemia, congenital aplastic anemia, myelofibrosis, and hypoplastic anemias due to myelotoxic drugs. It was originally developed in the 1960s and is known for its strong anabolic effects.
Oxymetholone works by mimicking testosterone in the body, binding to androgen receptors in muscle cells to promote protein synthesis and nitrogen retention, leading to increased muscle mass and strength. It also stimulates erythropoietin production and directly activates bone marrow stem cells, increasing red blood cell mass and improving oxygen delivery to tissues.
In non-medical bodybuilding contexts, oxymetholone is commonly referenced for rapid mass and strength gains, often described as one of the most potent oral bulking compounds. However, its use carries significant risks including hepatotoxicity, blood lipid changes, and androgenic side effects. The compound is prohibited by WADA at all times under S1.1 Anabolic Androgenic Steroids. Such use falls outside approved indications.
Oxymetholone is a potent 17α-alkylated oral anabolic steroid with strong anabolic effects, approved for treating specific anemias.
Oxymetholone is a 17α-alkyl derivative of testosterone, which decreases oxidation of the molecule and allows for oral administration. This structural modification also contributes to its hepatotoxicity, as 17α-alkylated androgens are associated with liver function abnormalities and rare cases of liver tumors.
The compound works through two main mechanisms: it increases erythropoietin production from the kidneys and acts directly on bone marrow stem cells, encouraging them to divide and mature into red blood cells. A two-year carcinogenicity study in rats found a wide spectrum of neoplastic and non-neoplastic effects at various doses.
Clinical research in older men demonstrated that oxymetholone at 50 and 100 mg/day for 12 weeks significantly increased lean body mass by 3.3 and 4.2 kg respectively, and decreased total body fat by 2.6 and 2.5 kg. However, HDL cholesterol decreased significantly in both treatment groups.
Oxymetholone is FDA-approved for anemias caused by deficient red cell production. A prior authorization policy explicitly states that use for athletic performance enhancement is not medically necessary.
British Dragon offers several oral compounds with distinct characteristics. Oxanabol contains oxandrolone, a mild oral with a more favorable safety profile. Methanabol contains methandienone, another potent bulking oral that aromatizes to estrogen. Stanabol 10 contains stanozolol, a non-17α-alkylated oral with lower liver toxicity.
Oxydrol's distinguishing characteristic among these compounds is its extreme anabolic potency and its unique mechanism of stimulating erythropoiesis, which contributes to the rapid weight gain often reported in non-medical contexts.
The information below is provided for educational reference only. Oxymetholone is a prescription medication; medical use requires appropriate diagnosis, clinical supervision, and ongoing monitoring. Non-medical use falls outside approved indications.
In clinical practice, the standard oxymetholone dose for adults and children is 1 to 5 mg/kg body weight per day, often divided into two or three doses. A cohort study of 110 adult aplastic anemia patients used an initial daily dose of 150 mg in 66.4% of patients. In non-medical bodybuilding contexts, oxymetholone is commonly referenced at 50 to 100 mg daily, though such use falls outside approved indications and carries substantial risks.
| Use Case | Common Reference Range | Frequency |
|---|---|---|
| Clinical (anemia) | 1–5 mg/kg | Daily, divided doses |
| Clinical (aplastic anemia study) | 150 mg | Daily |
| Non-medical (reported) | 50–100 mg | Daily, divided doses |
These non-medical ranges represent community-reported practices and are not derived from controlled clinical trials for performance enhancement. The clinical study using 100 mg/day noted modest increases in liver transaminases and significant HDL cholesterol decreases.
In non-medical bodybuilding contexts, oxymetholone is frequently referenced as a kick-start compound for bulking cycles, stacked with injectable testosterone such as Testabol Depot. Because it does not aromatize to estrogen, it does not cause gynecomastia directly, though it can still cause water retention.
Cycle duration in non-medical contexts is typically limited to 4–6 weeks due to hepatotoxicity concerns. Bloodwork including liver function tests, lipids, and hematocrit is commonly referenced before and during use.
Clinical monitoring recommendations include periodic liver function tests, serum lipids, and hemoglobin/hematocrit checks. A prior authorization policy notes that oxymetholone may cause peliosis hepatitis, liver cell tumors, and blood lipid changes, and may stunt bone growth in children.
In clinical studies, side effects observed included virilization (n=2), weight gain and edema (n=3), and signs of hepatotoxicity (n=2), all reversible after dose reduction or cessation. A cohort study of aplastic anemia patients found that 17.9% discontinued treatment due to side effects, especially hepatitis, and androgenic side effects occurred in 55.5% mostly within the first month.
Oxymetholone suppresses endogenous testosterone production, requiring post-cycle therapy to restore natural hormone levels. In non-medical contexts, PCT protocols typically involve SERMs such as Clomiphene or Tamoxifen, beginning after the compound has cleared the system.
Oxymetholone has approved dosing for specific medical indications. Any information about non-medical use is derived from user-reported practices and is not validated by controlled clinical research. This information does not constitute medical advice.
Oxymetholone is a prescription anabolic steroid with boxed warnings for serious liver toxicity and blood lipid changes. It is contraindicated in pregnancy and certain medical conditions.
Anabolic steroids including oxymetholone have boxed warnings for peliosis hepatitis, a condition in which liver and sometimes splenic tissue is replaced with blood-filled cysts. These cysts are sometimes present with minimal hepatic dysfunction but have been associated with liver failure and intra-abdominal hemorrhage.
Oxymetholone is contraindicated in pregnancy (Category X), known or suspected carcinoma of the prostate or male breast, carcinoma of the breast in females with hypercalcemia, nephrosis, and severe hepatic dysfunction.
Non-medical use of oxymetholone falls outside approved indications. Prior authorization policies explicitly state that use to enhance athletic performance is not medically necessary. Product purity does not establish that non-medical use is safe or appropriate.
Boxed warnings include liver cell tumors (most often benign and androgen-dependent, but fatal malignant tumors have been reported) and blood lipid changes including decreased HDL and sometimes increased LDL, which may have a serious impact on atherosclerosis and coronary artery disease risk.
Other adverse effects include virilization in women (deepening of voice, hirsutism, acne, clitoral enlargement, menstrual irregularities) which may be irreversible, and premature closure of epiphyses in children. A study in older men found that 100 mg/day of oxymetholone increased liver transaminases, and both 50 and 100 mg/day significantly decreased HDL cholesterol.
In a cohort study of aplastic anemia patients, 17.9% discontinued treatment due to side effects, especially hepatitis, and androgenic side effects occurred in 55.5% of patients.
Oxymetholone is not appropriate for everyone. Contraindications include pregnancy, prostate cancer, male breast cancer, nephrosis, and severe hepatic dysfunction. Caution is advised in patients with cardiovascular disease, diabetes, or edema.
Geriatric patients treated with androgens may be at increased risk of developing prostatic hypertrophy.
Clinical monitoring recommendations include periodic liver function tests, serum lipids, hemoglobin/hematocrit, and in children, radiographic examinations of bone age every 6 months. In women with disseminated breast carcinoma, frequent determination of urine and serum calcium levels is recommended.
Patients should report signs of liver problems including dark urine, tiredness, decreased appetite, upset stomach, stomach pain, vomiting, or yellowing of the skin or eyes.
Store tablets in a cool, dry place in the original packaging. Keep out of reach of children. Inspect tablets before use and do not use if they appear damaged or compromised.
Oxydrol 50 mg is supplied through the official British Dragon distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official British Dragon distribution chain.
To verify your Oxydrol 50 mg product, use the security code on the packaging and cross-check it on the British Dragon official site. Official British Dragon presentation and original packaging help reinforce product legitimacy and buyer confidence.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve tablet stability and overall product integrity throughout shelf life.
Store at controlled room temperature (15–25°C) in a cool, dry place, away from direct light and moisture. Keep tablets in their original packaging until use to protect from humidity.
Inspect tablets before use and do not use if they appear discolored, cracked, or otherwise compromised. Keep out of reach of children.
Answers to common questions about Oxydrol 50 mg, the Oxymetholone compound, and its applications.
Oxydrol 50 mg contains oxymetholone, a potent oral anabolic steroid. In clinical medicine, it is approved for anemias caused by deficient red blood cell production, including aplastic anemia and myelofibrosis. In non-medical bodybuilding contexts, it is commonly referenced for rapid mass and strength gains, though such use falls outside approved indications.
Clinical dosing is 1–5 mg/kg body weight per day, often divided into two or three doses. In non-medical contexts, oxymetholone is commonly referenced at 50–100 mg daily. These non-medical practices are not derived from controlled clinical trials for performance enhancement.
Yes, oxymetholone suppresses endogenous testosterone production, requiring post-cycle therapy to restore natural hormone levels. In non-medical contexts, PCT protocols typically involve SERMs such as Clomiphene or Tamoxifen.
Oxymetholone binds to androgen receptors in muscle cells, promoting protein synthesis and nitrogen retention. It also increases erythropoietin production and directly activates bone marrow stem cells, increasing red blood cell mass. Clinical research in older men demonstrated significant increases in lean body mass and decreases in body fat.
Clinical response in anemia often requires a minimum trial of 3 to 6 months. In non-medical contexts, users commonly report rapid weight and strength gains within the first 1–2 weeks of use, though individual response varies. A 12-week clinical study observed significant lean mass gains.
There is no universally established "best" oral steroid, and oxymetholone has not been validated in controlled trials for performance outcomes. Its potent anabolic effects make it a commonly referenced option for bulking, but its hepatotoxicity and blood lipid changes are significant drawbacks.
Oxydrol and Oxanabol have different characteristics. Oxymetholone is a potent bulking compound with significant hepatotoxicity, while oxandrolone is a mild oral with a more favorable safety profile. They are used for different purposes in non-medical contexts.
Oxydrol and Methanabol are both potent bulking orals but differ in other ways. Oxymetholone is a 17α-alkylated compound that does not aromatize, while methandienone aromatizes to estrogen. Both carry significant hepatotoxicity risks.
Oxydrol 50 mg is labeled at 50 mg of oxymetholone per tablet. Clinical dosing is 1–5 mg/kg body weight per day, so a single 50 mg tablet represents a substantial dose for many individuals. A cohort study used 150 mg daily in most patients.
Oxydrol 50 mg is labeled at 50 mg of oxymetholone per tablet. It is supplied as oral tablets in packs of 50 tablets manufactured by British Dragon.
No. Oxymetholone is a 17α-alkylated anabolic steroid with boxed warnings for peliosis hepatitis and liver cell tumors. A study in older men found that 100 mg/day increased liver transaminases. A cohort study of aplastic anemia patients found that 17.9% discontinued treatment due to side effects, especially hepatitis.